Allergan Aesthetics Unveiling New AA Signature Program, Immersive Booth at IMCAS World Congress 2025

Allergan Aesthetics, an AbbVie company, is elevating the patient journey with the launch of its news AA Signature Program at the International Master Course of Aging Science (IMCAS) World Congress 2025 in Paris from January 31 through February 1. 

The new AA Signature Program will provide a personalized approach to treatment planning, in combination with Allergan Aesthetics’ advanced facial portfolio to address patient needs and treat different areas of the face, according to a press release. 

The AA Signature Program will offer practitioners with an innovative approach to treatment planning using the Allergan Aesthetics advanced product portfolio to design signature looks for each patient, addressing different patient needs, including lift, definition, and skin quality. Research found that 8 in 10 patients proceed with treatment plans following a holistic consultation and clinics utilizing treatment plans addressing multiple areas of the face see a 68% higher retention rate compared to those that focus on only one area per treatment. 

Allergan Medical Institute is hosting a symposium called AA Signatures: Innovative Patient Journey to launch the program. It will focus on how to design a patient’s signature look using the Allergan Aesthetics portfolio of high-quality products, education and support services through real world examples from experts. 

A live injection session will be performed from the Allergan Center of Excellence in Italy and will focus specifically on lift from the AA Signature Program, which addresses research finding that sagginess is one of the most undesirable facial features. 

Source: Allergan Aesthetics press release. January 24, 2025.